<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01178515</url>
  </required_header>
  <id_info>
    <org_study_id>Milk, Cardiovas risk, children</org_study_id>
    <secondary_id>1-865-6540</secondary_id>
    <nct_id>NCT01178515</nct_id>
  </id_info>
  <brief_title>Low Fat Milk Intake and Cardio Vascular Risk (CVR) Indicators in Children</brief_title>
  <official_title>Impact of Low Fat Milk Intake on Cardiovascular Risk Indicators in Children 6-13 Years of Age</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto Nacional de Salud Publica, Mexico</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Instituto Nacional de Salud Publica, Mexico</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Substituting whole milk intake for defatted milk will improve indicators of cardiovascular
      risk, i.e. total cholesterol, triglycerides, Low Density Lipoprotein (LDL) and High Density
      Lipoprotein (HDL)cholesterol, apolipoproteins: ApoB100, Lp(a) and ApoA in a sample of Mexican
      children 6-13 years of age.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Double blind trial in 600 children 6-13 years of age residing in 12 boarding schools. Schools
      will be randomized to distribute three types of milk namely: full fat milk (3% fat),
      partially defatted milk (2% fat) or defatted milk (1% fat) for 90 days of effective exposure
      (4 months total duration). Subjects will receive 400 mL of the corresponding milk every day
      (200 mL breakfast and 200 mL night meal) from Monday through Friday. During week ends they
      will eat a freely chosen diet at home. Milk intake will be measured every day. Diet by 24
      h-recall. will be evaluated every month. Blood samples will be obtained at the beginning and
      at the end of the intervention.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2010</start_date>
  <completion_date type="Actual">May 2011</completion_date>
  <primary_completion_date type="Actual">February 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cardiovascular risk indicators</measure>
    <time_frame>4 months</time_frame>
    <description>Cardiovascular risk is indicated by several determinations of blood fats namely: Total cholesterol, triglicerides, Low-density lipoprotein (LDL) and High density lipoprotein (HDL) cholesterol, lipoproteins: Apo a1,Apo B100 and Lp(a)</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">650</enrollment>
  <condition>Cardiovascular Diseases</condition>
  <arm_group>
    <arm_group_label>Full fat milk</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Full fat milk contain 3% fat</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Partially defatted milk</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Partially defatted milk contains 2% of fat</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Defatted milk</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Defatted milk contains 1% fat</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Modification of the content of fat in milk</intervention_name>
    <description>Comparison of three levels of fat content in cow´s milk</description>
    <arm_group_label>Full fat milk</arm_group_label>
    <other_name>Liconsa milk</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Modification of the content of cows milk</intervention_name>
    <description>Comparison of three levels of fat content in cows' milk</description>
    <arm_group_label>Partially defatted milk</arm_group_label>
    <other_name>Liconsa low fat milk</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Modification of the fat content of cows´ milk</intervention_name>
    <description>Comparison of three levels of fat content in cow´milk</description>
    <arm_group_label>Defatted milk</arm_group_label>
    <other_name>Liconsa defatted milk</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Attending selected boarding schools

        Exclusion Criteria:

          -  No lactose intolerance
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>13 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Salvador Villalpando, MD, Ph D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Instituto Nacional de Salud Publica, Mexico</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Teresa Shamah, M. Sc.</last_name>
    <role>Study Chair</role>
    <affiliation>Instituto Nacional de Salud Publica, Mexico</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yaveth Lara, M Sc</last_name>
    <role>Study Chair</role>
    <affiliation>Instituto Nacional de Salud Publica, Mexico</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Comisíon para el Desarrollo de Pueblos Indigenas</name>
      <address>
        <city>Pachuca</city>
        <state>Hidalgo</state>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <reference>
    <citation>Stevens G, Dias RH, Thomas KJ, Rivera JA, Carvalho N, Barquera S, Hill K, Ezzati M. Characterizing the epidemiological transition in Mexico: national and subnational burden of diseases, injuries, and risk factors. PLoS Med. 2008 Jun 17;5(6):e125. doi: 10.1371/journal.pmed.0050125.</citation>
    <PMID>18563960</PMID>
  </reference>
  <reference>
    <citation>Berenson GS, Srinivasan SR, Bao W, Newman WP 3rd, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med. 1998 Jun 4;338(23):1650-6.</citation>
    <PMID>9614255</PMID>
  </reference>
  <reference>
    <citation>Freedman DS. Clustering of coronary heart disease risk factors among obese children. J Pediatr Endocrinol Metab. 2002 Sep-Oct;15(8):1099-108.</citation>
    <PMID>12387507</PMID>
  </reference>
  <reference>
    <citation>Aguilar-Salinas CA, Gómez Pérez FJ, Rull Rodrigo J, Villalpando S, Barquera S, Rojas R. Prevalence of dyslipidemias in the 2006 Encuesta Nacional de Salud y Nutrición. Salud Pub Mex, 2010; 52 Sppl 1: S44-S53.</citation>
  </reference>
  <reference>
    <citation>Corvalán C, Uauy R, Kain J, Martorell R. Obesity indicators and cardiometabolic status in 4-y-old children. Am J Clin Nutr. 2010 Jan;91(1):166-74. doi: 10.3945/ajcn.2009.27547. Epub 2009 Nov 18.</citation>
    <PMID>19923378</PMID>
  </reference>
  <reference>
    <citation>Villalpando S, Carrión C, Barquera S, Olaiz G, Robledo R. The body mass index is associated with hyperglycemia and alterations of some components of the metabolic syndrome in Mexican adolescents aged 10-19 years. Salud Pub Mex 2007; 49:s324-s330.</citation>
  </reference>
  <reference>
    <citation>Webber LS, Srinivasan SR, Wattigney WA, Berenson GS. Tracking of serum lipids and lipoproteins from childhood to adulthood. The Bogalusa Heart Study. Am J Epidemiol. 1991 May 1;133(9):884-99.</citation>
    <PMID>2028978</PMID>
  </reference>
  <verification_date>June 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 9, 2010</study_first_submitted>
  <study_first_submitted_qc>August 9, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 10, 2010</study_first_posted>
  <last_update_submitted>June 24, 2011</last_update_submitted>
  <last_update_submitted_qc>June 24, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 27, 2011</last_update_posted>
  <responsible_party>
    <name_title>Dr. Salvador Villalpando</name_title>
    <organization>Instituto Nacional de Salud Publica</organization>
  </responsible_party>
  <keyword>epidemiological risk</keyword>
  <keyword>diet</keyword>
  <keyword>fat intake</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

